advertisement
Kolomeyer NN 23
Showing records 1 to 23 | Display all abstracts from Kolomeyer NN107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Shalaby WS; Shalaby WS
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Wong JC
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Shalaby WS
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Wong JC
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Patel S
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Savsani E
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Lam SS
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Mahmoudzadeh R; Salabati M
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Bechay J
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Razeghinejad R
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Zadrozny I
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Lee D
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Reyes J
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Shukla AG
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Zhang Q
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Shukla AG; Myers JS
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Sharpe J; Sharpe J; Lee D
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Pro MJ; Moster MR
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Myers JS
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Dunn JP
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Kolomeyer NN; Kolomeyer NN
Journal of Glaucoma 2023; 32: 389-395
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Kolomeyer NN; Kolomeyer NN
Ocular Immunology and Inflammation 2023; 0: 1-7
107802 Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy
Razeghinejad R; Pro MJ; Moster MR; Garg Shukla A
Journal of Glaucoma 2023; 32: 389-395
